Improving Reimbursement for Blood and Marrow Transplants

On January 1, 2017, the Centers for Medicare and Medicaid Services enacted a significant policy change improving access to blood and marrow transplants done on an outpatient setting for Medicare patients diagnosed with life-threatening blood cancers. However, while this move is a step in the right direction, this rule does not address the vast majority of transplants (97 percent) that are performed in the inpatient setting. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or

Leave a Reply